<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  See FDA-Approved Medication Guide<BR>                  <BR>                  <BR>                     Caution patients that pantoprazole sodium delayed-release tablets should not be split, crushed, or chewed.<BR>                     Tell patients that pantoprazole sodium delayed-release tablets should be swallowed whole, with or without food in the stomach. <BR>                     Let patients know that concomitant administration of antacids does not affect the absorption of pantoprazole sodium delayed-release tablets.<BR>                     Advise patients to immediately report and seek care for any cardiovascular or neurological symptoms including palpitation, dizziness, seizures, and tetany as these may be signs of hypomagnesemia [see Warnings and Precautions (5.6)].<BR>                     Advise patients to immediately report and seek care for diarrhea that does not improve. This may be a sign of Clostridium difficile associated diarrhea [see<BR>                        Warnings and Precautions (<BR>                        <BR>                           5.4Â )]<BR><BR>                     <BR>                  <BR>                  Manufactured In Israel By:<BR>                  <BR>                     TEVA PHARMACEUTICAL IND. LTD.<BR>                  <BR>                  Jerusalem, 91010, Israel<BR>                  Manufactured For:<BR>                  <BR>                     TEVA PHARMACEUTICALS USA<BR>                  <BR>                  Sellersville, PA 18960<BR>                  Rev. K 10/2012<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>